MDMA Therapy: A New Hope for Chronic Pain Sufferers
We know these medicines are incredibly safe, we know how to screen people to make sure it's safe for them. So in a clinical trial, like people, a lot of people that are normal patients would never get in because they're too unwell, they have too many problems right.
Chronic pain isn't just a physical ailment; it often brings emotional and mental challenges that can be overwhelming. In this episode of 'People First Radio', Dr. Pamela Kryskow sheds light on an innovative approach to managing chronic pain through psychedelic assisted therapy. Dr. Kryskow, the medical chair of Vancouver Island University's Psychedelic Assisted Therapy Program, discusses how MDMA and psilocybin could offer relief where traditional methods fall short.
As a founding board member of the Psychedelic Association of Canada and the medical lead for Roots to Thrive, she brings a wealth of expertise to the conversation. The clinical trial she outlines aims to create a safe, supportive environment where patients can explore and heal from deep-seated emotional issues that exacerbate their pain. This groundbreaking trial involves rigorous psychological and medical assessments to ensure patient safety, followed by carefully structured therapy sessions. Dr.
Kryskow highlights the need for personalized treatment plans, as each patient's journey is unique. She also calls for political backing and nonprofit research to help bring these promising therapies into mainstream medicine. This episode is a must-listen for anyone affected by chronic pain or interested in the future of mental health treatment.